Accuray Incorporated Files Registration Statement for Proposed Initial Public Offering
Accuray Incorporated Files Registration Statement for Proposed Initial Public Offering
November 13, 2006 at 12:00 AM EST
Sunnyvale, Calif., November 13, 2006 – Accuray Incorporated (“Accuray”) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of shares of its common stock. Copies of the Accuray registration statement on Form S-1 can be accessed over the internet through the SEC's website at edgar.sec.gov. The number of shares to be offered and the price range for the offering have not yet been determined. The shares of common stock to be sold in this offering are proposed to be sold by Accuray and certain stockholders.
J.P. Morgan Securities Inc. and UBS Investment Bank will be acting as joint bookrunning managers, with Piper Jaffray & Co. as lead manager and Jefferies & Company, Inc. as co-manager for the offering. This offering will be made only by means of a prospectus. Copies of the preliminary prospectus for this offering may be obtained, when available, from J.P. Morgan Securities Inc., Prospectus Library, 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245 and UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, NY 10171.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Accuray designs, develops and sells the CyberKnife® System, an image-guided robotic radiosurgery system used for the treatment of solid tumors anywhere in the body.
This press release contains certain forward-looking statements that involve risks and uncertainties. Forward-looking statements include Accuray's plans to sell securities in an initial public offering. Such statements are only predictions and actual results may differ materially from those anticipated in these forward-looking statements.
Accuray, the Accuray logo and CyberKnife are among trademarks or registered trademarks of Accuray Incorporated.
J.P. Morgan Securities Inc. and UBS Investment Bank will be acting as joint bookrunning managers, with Piper Jaffray & Co. as lead manager and Jefferies & Company, Inc. as co-manager for the offering. This offering will be made only by means of a prospectus. Copies of the preliminary prospectus for this offering may be obtained, when available, from J.P. Morgan Securities Inc., Prospectus Library, 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245 and UBS Investment Bank, Prospectus Department, 299 Park Avenue, New York, NY 10171.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Accuray designs, develops and sells the CyberKnife® System, an image-guided robotic radiosurgery system used for the treatment of solid tumors anywhere in the body.
This press release contains certain forward-looking statements that involve risks and uncertainties. Forward-looking statements include Accuray's plans to sell securities in an initial public offering. Such statements are only predictions and actual results may differ materially from those anticipated in these forward-looking statements.
Accuray, the Accuray logo and CyberKnife are among trademarks or registered trademarks of Accuray Incorporated.